London-based specialist healthcare investment adviser GHO Capital Partners LLP, or Global Healthcare Opportunities, sold Caprion Biosciences to Arsenal Capital Partners Inc.
Caprion provides specialized flow cytometry immune monitoring and quantitative mass spectrometry proteomics services to the biopharmaceutical industry.
Arsenal is a middle-market private equity firm investing in specialty industrials and healthcare businesses.
